SOMNOMED LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.215 AUD | +2.38% |
|
0.00% | -57.00% |
Presenter SpeechGaetano Russo (Executives)Well, good morning. Terry tells me that a quorum is ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
SomnoMed Limited is an Australia-based company, which is engaged in producing and selling devices for the oral treatment of sleep-related disorders. The Company provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is focused on the commercialization of the SomnoDent and other oral devices for sleep-related disorders. The Companyâs segments include North America, Europe, Asia Pacific, CORE, and RSS. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. It also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances.
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.21
AUD
Average target price
0.45
AUD
Spread / Average Target
+114.29%
| 1st Jan change | Capi. | |
|---|---|---|
| -57.00% | 18.9M | |
| -3.79% | 184B | |
| -0.84% | 108B | |
| -3.75% | 67.82B | |
| +3.45% | 51.05B | |
| +9.04% | 44.67B | |
| +3.40% | 41.78B | |
| +3.21% | 26.78B | |
| +3.66% | 26.59B | |
| +15.23% | 25.86B |
- Stock Market
- Equities
- SOM Stock
- News SomnoMed Limited
- Transcript : SomnoMed Limited - Shareholder/Analyst Call